Entrada Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director KIM PETER S
Apr 10 16:39 ET
Entrada Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director KIM PETER S
Apr 1 16:34 ET
Entrada Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director KIM PETER S
Mar 26 18:00 ET
Entrada Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director KIM PETER S
Mar 21 16:37 ET
Entrada Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer WENTWORTH KORY JAMES
Mar 19 16:38 ET
Entrada Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer WENTWORTH KORY JAMES
Mar 8 16:43 ET
Entrada Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Dowden Nathan J
Mar 8 16:38 ET
Entrada Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Doshi Dipal
Mar 5 19:54 ET
Entrada Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer WENTWORTH KORY JAMES
Mar 5 19:49 ET
Entrada Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Dowden Nathan J
Mar 5 19:49 ET
Entrada Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Sethuraman Natarajan
Mar 5 19:49 ET
Entrada Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Doshi Dipal
Feb 20 16:43 ET
Entrada Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Redmile Group, LLC(3.8%),Jeremy C. Green(3.8%)
Feb 14 16:29 ET
Entrada Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Roche Finance Ltd(8.2%),Roche Holding Ltd(8.2%)
Feb 14 16:22 ET
Entrada Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-T. ROWE PRICE ASSOCIATES, INC.(9.0%)
Feb 14 10:17 ET
Entrada Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Doshi Dipal
Jan 18 00:00 ET
Entrada Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer WENTWORTH KORY JAMES
Dec 26, 2023 00:00 ET
Entrada Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Doshi Dipal
Dec 22, 2023 16:38 ET
Entrada Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Doshi Dipal
Nov 13, 2023 16:35 ET
Entrada Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Doshi Dipal
Oct 19, 2023 17:27 ET
No Data
No Data